View of Evaluation of Continuous Subcutaneous Insulin Infusion (CSII) as an Alternative Therapy for Type 1 Diabetes in Paediatric Patients: A Focus on HbA1c Levels.

https://ajost.journals.ly/ojs/index.php/1/sitemap